Paragangliomas of the Head and Neck: An Overview from Diagnosis to Genetics
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827
SDHA is a tumor suppressor gene causing paraganglioma
Burnichon, N., Brière, J.-J., Libé, R., Vescovo, L., Rivière, J., Tissier, F., Jouanno, E., Jeunemaitre, X., Bénit, P., Tzagoloff, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq206 · Cited by 650
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity
Dahia, P. L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3648 · Cited by 545
van Nederveen, F. H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R. A., de Bruyn, E. M., Sleddens, H. F., Derkx, P., Rivière, J., Dannenberg, H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70164-0 · Cited by 538 · cited 2×
“PGL and other tumor tissues with SDH-deficiency caused by a mutation in any of the SDH family of genes may be screened for utilizing the SDHB immunohistochemical assay [22, 23] (Fig.”
BackgroundMethodNational Cancer Data Base report on malignant paragangliomas of the head and neck
Lee, J. H., Barich, F., Karnell, L. H., Robinson, R. A., Zhen, W. K., Gantz, B. J., Hoffman, H. T., & American College of Surgeons Commission on Cancer and the American Cancer Society (2002) · Cancer · doi:10.1002/cncr.10252 · Cited by 427 · cited 1×
“It has long been recognized that chronic hypoxia is a risk factor for PGL including those who lived at high altitude, with increased risk particularly in women [1, 2].”
BackgroundMiettinen, M., Wang, Z.-F., Sarlomo-Rikala, M., Osuch, C., Rutkowski, P., & Lasota, J. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182260752 · Cited by 363 · cited 1×
“Histologic features associated with SDH-deficient GIST include epithelioid morphology, multinodular with plexiform involvement of the gastric wall of the stomach predominantly occurring in children and young adults [33].”
BackgroundBaysal, B. E., Willett-Brozick, J. E., Lawrence, E. C., Drovdlic, C. M., Savul, S. A., McLeod, D. R., Yee, H. A., Brackmann, D. E., Slattery, W. H., Myers, E. N., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.3.178 · Cited by 339
Korpershoek, E., Favier, J., Gaal, J., Burnichon, N., van Gessel, B., Oudijk, L., Badoual, C., Gadessaud, N., Venisse, A., Bayley, J.-P., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1043 · Cited by 277 · cited 1×
“While this marker may aid in evaluation for this specific gene alteration, the rarity of this mutation in the HN, and as SDHB screening is also altered in SDHA mutated tumors, the added utility of SDHA in this cohort may be limited [26].”
BackgroundGill, A. J., Benn, D. E., Chou, A., Clarkson, A., Muljono, A., Meyer-Rochow, G. Y., Richardson, A. L., Sidhu, S. B., Robinson, B. G., & Clifton-Bligh, R. J. (2010) · Human Pathology · doi:10.1016/j.humpath.2009.12.005 · Cited by 277 · cited 3×
“PGL and other tumor tissues with SDH-deficiency caused by a mutation in any of the SDH family of genes may be screened for utilizing the SDHB immunohistochemical assay [22, 23] (Fig.”
BackgroundMethodThe NGS in PPGL (NGSnPPGL) Study Group, Toledo, R. A., Burnichon, N., Cascon, A., Benn, D. E., Bayley, J.-P., Welander, J., Tops, C. M., Firth, H., Dwight, T., et al. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.185 · Cited by 275
Papathomas, T. G., Oudijk, L., Persu, A., Gill, A. J., van Nederveen, F., Tischler, A. S., Tissier, F., Volante, M., Matias-Guiu, X., Smid, M., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.41 · Cited by 227 · cited 1×
“An antibody specific to the SDHA protein shows a pattern of loss specific to tumors with SDHA mutations, with SDHA expression retained in SDHB, SDHC, and SDHD altered tumors [25].”
BackgroundWilliamson, S. R., Eble, J. N., Amin, M. B., Gupta, N. S., Smith, S. C., Sholl, L. M., Montironi, R., Hirsch, M. S., & Hornick, J. L. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.86 · Cited by 225 · cited 1×
“SDH-deficient RCC shows cuboidal cells with indistinct cell borders vacuolated/bubbly cytoplasm, and monomorphic appearing more eosinophic cells [34, 35].”
BackgroundHead and neck paragangliomas: clinical and molecular genetic classification
Offergeld, C., Brase, C., Yaremchuk, S., Mader, I., Rischke, H. C., Gläsker, S., Schmid, K. W., Wiech, T., Preuss, S. F., Suárez, C., et al. (2012) · Clinics · doi:10.6061/clinics/2012(sup01)05 · Cited by 218
Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level
Rodríguez-Cuevas, S., López-Garza, J., & Labastida-Almendaro, S. (1998) · Head & Neck · doi:10.1002/(sici)1097-0347(199808)20:5<374::aid-hed3>3.0.co;2-v · Cited by 209 · cited 1×
“It has long been recognized that chronic hypoxia is a risk factor for PGL including those who lived at high altitude, with increased risk particularly in women [1, 2].”
Background15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5
Benn, D. E., Robinson, B. G., & Clifton-Bligh, R. J. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0268 · Cited by 197 · cited 1×
“The majority of PGLs with SDHD mutation arise in the carotid body though have been described in all 4 HN sites [29, 31].”
BackgroundMulti-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas
Castro-Vega, L. J., Letouzé, E., Burnichon, N., Buffet, A., Disderot, P.-H., Khalifa, E., Loriot, C., Elarouci, N., Morin, A., Menara, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7044 · Cited by 196
Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology
Gill, A. J., Pachter, N. S., Chou, A., Young, B., Clarkson, A., Tucker, K. M., Winship, I. M., Earls, P., Benn, D. E., Robinson, B. G., et al. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318227e7f4 · Cited by 191 · cited 1×
“SDH-deficient RCC shows cuboidal cells with indistinct cell borders vacuolated/bubbly cytoplasm, and monomorphic appearing more eosinophic cells [34, 35].”
BackgroundAberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad
Haller, F., Moskalev, E. A., Faucz, F. R., Barthelmeß, S., Wiemann, S., Bieg, M., Assie, G., Bertherat, J., Schaefer, I.-M., Otto, C., et al. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-14-0254 · Cited by 189 · cited 13×
“However, in a recent analysis ~10% were identified to have SDHA, SDHB, or SDHC gene mutations [39].”
BackgroundInfluentialDénes, J., Swords, F., Rattenberry, E., Stals, K., Owens, M., Cranston, T., Xekouki, P., Moran, L., Kumar, A., Wassif, C., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3399 · Cited by 188 · cited 1×
“Whereas SDH-deficient pituitary adenomas were without unique characteristic morphologic features in one study, they showed prominent cellular vacuolization in another [36, 37].”
BackgroundCurrent Approaches and Recent Developments in the Management of Head and Neck Paragangliomas
Taïeb, D., Kaliski, A., Boedeker, C. C., Martucci, V., Fojo, T., Adler, J. R., & Pacak, K. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1026 · Cited by 170
SDHAF2 (PGL2-SDH5) and Hereditary Head and Neck Paraganglioma
Kunst, H. P. M., Rutten, M., de Mönnink, J. P., Hoefsloot, L. H., Timmers, H. J. L. M., Marres, H. A. M., Jansen, J. C., Kremer, H., Bayley, J., & Cremers, C. W. R. J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0420 · Cited by 163
Pheochromocytoma and Paraganglioma
Fishbein, L. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.09.006 · Cited by 161
Familial SDHA Mutation Associated With Pituitary Adenoma and Pheochromocytoma/Paraganglioma
Dwight, T., Mann, K., Benn, D. E., Robinson, B. G., McKelvie, P. A., Gill, A. J., Winship, I., & Clifton-Bligh, R. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1400 · Cited by 118 · cited 1×
“Whereas SDH-deficient pituitary adenomas were without unique characteristic morphologic features in one study, they showed prominent cellular vacuolization in another [36, 37].”
BackgroundNeumann, H. P. H., Sullivan, M., Winter, A., Malinoc, A., Hoffmann, M. M., Boedeker, C. C., Bertz, H., Walz, M. K., Moeller, L. C., Schmid, K. W., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0114 · Cited by 98
Genetics of hereditary head and neck paragangliomas
Boedeker, C. C., Hensen, E. F., Neumann, H. P. H., Maier, W., van Nederveen, F. H., Suarez, C. M., Kunst, H. P. M., Rodrigo, J. P., Takes, R. P., Pellitteri, P. K., et al. (2013) · Head & Neck · doi:10.1002/hed.23436 · Cited by 97 · cited 9×
“No individual or collection of histologic features can predict which HNPGLs will go on to have aggressive behavior and potentially metastasize.”
BackgroundInfluentialHead and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients
Piccini, V., Rapizzi, E., Bacca, A., Trapani, G. D., Pulli, R., Giaché, V., Zampetti, B., Cordisco, E. L., Canu, L., Corsini, E., et al. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0369 · Cited by 82 · cited 1×
“The majority of PGLs with SDHD mutation arise in the carotid body though have been described in all 4 HN sites [29, 31].”
BackgroundThe management of head-and-neck paragangliomas
Capatina, C. A.-M., Ntali, G., Karavitaki, N., & Grossman, A. B. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0223 · Cited by 79
Pheochromocytoma and Paraganglioma
Pacák, K., & Wimalawansa, S. J. (2015) · Endocrine Practice · doi:10.4158/ep14481.ra · Cited by 77 · cited 3×
“Additionally, these altered pathways enable the tumor cells to grow even in a low oxygen environment [4].”
BackgroundCarney triad can be (rarely) associated with germline succinate dehydrogenase defects
Boikos, S. A., Xekouki, P., Fumagalli, E. R., Faucz, F. R., Raygada, M. J., Szarek, E., Ball, E. R., Kim, S., Miettinen, M., Helman, L. J., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.142 · Cited by 69 · cited 13×
“However, in a recent analysis ~10% were identified to have SDHA, SDHB, or SDHC gene mutations [39].”
BackgroundInfluentialThe Presence of SDHB Mutations Should Modify Surgical Indications for Carotid Body Paragangliomas
Ellis, R. J., Patel, D., Prodanov, T., Nilubol, N., Pacák, K., & Kebebew, E. (2013) · Annals of Surgery · doi:10.1097/sla.0000000000000283 · Cited by 67
Baysal, B. E., & Maher, E. R. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0226 · Cited by 64
Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad
Haller, F., Moskalev, E. A., Faucz, F. R., Barthelmesz, S., Wiemann, S., Bieg, M., Assie, G., Bertherat, J., Schaefer, I.-M., Otto, C., et al. (2015) · Endocrine Abstracts · doi:10.1530/endoabs.38.ja3 · Cited by 62
Malignant head and neck paragangliomas: Treatment efficacy and prognostic indicators
Sethi, R. V., Sethi, R. K. V., Herr, M. W., & Deschler, D. G. (2013) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2013.03.010 · Cited by 57
SDHD Immunohistochemistry: A New Tool to ValidateSDHxMutations in Pheochromocytoma/Paraganglioma
Menara, M., Oudijk, L., Badoual, C., Bertherat, J. Y., Lussey‐Lepoutre, C., Amar, L., Iturrioz, X., Sibony, M., Zinzindohoué, F., de Krijger, R. R., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1870 · Cited by 55 · cited 1×
“Antibodies to SDHD protein have also been created which appear to have a screening effect with loss across the SDH complex of genes, similar to SDHB immunohistochemical staining pattern [27].”
Result
Metadata
- Authors
- Williams, M. D.
- Venue
- Head and Neck Pathology
- Published
- 2017-03-20
- Volume
- 11
- Issue
- 3
- Pages
- 278-287
- ISSN
- 1936-055X (ISSN-L)
- 1936-0568
- OpenAlex
- W2598559866
- Cited by
- 173
- References
- 34
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.